Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Breast cancer anti-estrogen resistance"'
Publikováno v:
American Heart Journal Plus, Vol 44, Iss , Pp 100416- (2024)
Breast cancer anti-estrogen resistance-1 (p130Cas/BCAR1) is an adaptor protein of the cas(Cas) family. This protein regulates multiple complex pathways in different organs including bones, pancreas, and immune and cardiovascular systems. Although pre
Externí odkaz:
https://doaj.org/article/bda935b4686641ccbdd050f4c95eb145
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Breast cancer anti-estrogen resistance 4 (BCAR4) is closely associated with colorectal cancer (CRC) initiation and propagation. However, the mechanisms underlying BCAR4 function in colon cancer remains largely unknown. In this stu
Externí odkaz:
https://doaj.org/article/a7ea9d15558d41599ec0199715e77e34
Autor:
Bo Deng, Tan Long, Hua Jin, Sha-Sha Jiang, Qunyou Tan, Shaolin Tao, Bin Jiang, Xiao-yang Wang, Chun-Guo Mao, Yan-Lian Yang, Yi Huang, Cheng-Yi Mao, Zhi-Yuan Hu
Publikováno v:
International Journal of Biological Sciences
Background: We investigated the roles of breast cancer anti-estrogen resistance 1 (BCAR1/p130Cas) in the formation and immunoevasion of invasive circulating tumor cells (CTCs) in lung adenocarcinoma (LUAD). Methods: Biomarkers of CTCs including BCAR1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5307dc64f7d43709821b14c0420d1f69
http://europepmc.org/articles/PMC8315020
http://europepmc.org/articles/PMC8315020
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 2, Pp 340-354 (2021)
Acta Pharmaceutica Sinica B, Vol 11, Iss 2, Pp 340-354 (2021)
Enormous studies have corroborated that long non-coding RNAs (lncRNAs) extensively participate in crucial physiological processes such as metabolism and immunity, and are closely related to the occurrence and development of tumors, cardiovascular dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1331163087be50317f3485f73580768
https://doi.org/10.1016/j.apsb.2020.10.001
https://doi.org/10.1016/j.apsb.2020.10.001
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Medicine
Background: Since long non-coding RNA breast cancer anti-estrogen resistance 4 (lncRNA BCAR4) is dysregulated in various types of cancers, we conducted a meta-analysis to determine its prognostic value in cancer. Methods: PubMed, EMBASE database, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d7bfe2f3cc62f99ed53fe163f51aff49
http://europepmc.org/articles/PMC6571273
http://europepmc.org/articles/PMC6571273
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 19, Iss 1, Pp 1-12 (2019)
Cancer Cell International, Vol 19, Iss 1, Pp 1-12 (2019)
Background Breast cancer anti-estrogen resistance 4 (BCAR4) is closely associated with colorectal cancer (CRC) initiation and propagation. However, the mechanisms underlying BCAR4 function in colon cancer remains largely unknown. In this study, we hy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e9ff5aa98f0939b3a15dcca79216762
https://doi.org/10.1186/s12935-019-0784-3
https://doi.org/10.1186/s12935-019-0784-3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Technology in Cancer Research & Treatment
Technology in Cancer Research & Treatment
Objective: To clarify the clinical significance of breast cancer anti-estrogen resistance protein 1 (BCAR1) expression in circulating tumor cells (CTCs) in the peripheral blood and tumor tissues in patients with early stage lung adenocarcinoma (ES-LU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56dd9d900867b7228b57809724707ef
https://doi.org/10.1177/1533033820983086
https://doi.org/10.1177/1533033820983086